BlackRock
TNYA icon

BlackRock’s Tenaya Therapeutics TNYA Stock Holding History

BlackRock’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Buy
4,008,719
+304,764
+8% +$231K ﹤0.01% 4061
2026
Q1 		$2.56M Sell
3,703,955
-244,631
-6% -$181K ﹤0.01% 4061
2025
Q4 		$2.81M Buy
3,948,586
+1,621,385
+70% +$2.21M ﹤0.01% 4021
2025
Q3 		$3.77M Sell
2,327,201
-405,599
-15% -$409K ﹤0.01% 3898
2025
Q2 		$1.67M Sell
2,732,800
-2,523,802
-48% -$1.28M ﹤0.01% 4117
2025
Q1 		$3M Sell
5,256,602
-39,874
-0.8% -$39.3K ﹤0.01% 3860
2024
Q4 		$7.57M Buy
5,296,476
+1,190,171
+29% +$2.67M ﹤0.01% 3556
2024
Q3 		$7.93M Buy
4,106,305
+32,249
+0.8% +$91K ﹤0.01% 3519
2024
Q2 		$12.6M Sell
4,074,056
-626,941
-13% -$2.59M ﹤0.01% 3247
2024
Q1 		$24.6M Buy
4,700,997
+914,173
+24% +$4.37M ﹤0.01% 2876
2023
Q4 		$12.3M Sell
3,786,824
-896,343
-19% -$1.93M ﹤0.01% 3283
2023
Q3 		$11.9M Buy
4,683,167
+1,047,019
+29% +$4.38M ﹤0.01% 3230
2023
Q2 		$21.3M Buy
3,636,148
+850,661
+31% +$4.94M ﹤0.01% 3005
2023
Q1 		$7.94M Buy
2,785,487
+524,792
+23% +$1.47M ﹤0.01% 3439
2022
Q4 		$4.54M Sell
2,260,695
-180,686
-7% -$441K ﹤0.01% 3766
2022
Q3 		$7.08M Sell
2,441,381
-21,548
-0.9% -$101K ﹤0.01% 3601
2022
Q2 		$13.9M Buy
2,462,929
+34,057
+1% +$276K ﹤0.01% 3310
2022
Q1 		$28.6M Buy
2,428,872
+555,928
+30% +$6.73M ﹤0.01% 2942
2021
Q4 		$35.5M Buy
1,872,944
+253,225
+16% +$5.52M ﹤0.01% 2908
2021
Q3 		$33.4M Buy
+1,619,719
New +$34.8M ﹤0.01% 2924

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

BlackRock's TNYA Position: Q2 2026 in Review

BlackRock increased its Tenaya Therapeutics (TNYA) stake by 8.2% in Q2 2026, buying an estimated $231K and bringing the position to 4,008,719 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #4061.

BlackRock first reported a position in TNYA in Q3 2021 and has held it in 20 quarters since. The position peaked at $35.5M in Q4 2021. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • BlackRock held 4,008,719 shares of Tenaya Therapeutics worth $2.96M as of Q2 2026.
  • BlackRock bought 304,764 Tenaya Therapeutics shares in Q2 2026, an estimated $231K.
  • Tenaya Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4061 holding.
  • BlackRock first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • BlackRock's Tenaya Therapeutics position peaked at $35.5M in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.